한글목차

심장판막 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 124억 1,000만 달러에서 2026년에는 142억 4,000만 달러로, CAGR 14.8%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 심장판막증 발생률 증가, 심장 수술 프로그램 확대, 인공심장판막 사용 증가, 수술적 판막 치환술 기술 발전, 심장 치료 시설의 확충 등이 주요 요인으로 꼽힙니다.

심장판막 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 240억 2,000만 달러에 달하며, CAGR은 14.0%에 달할 전망입니다. 예측 기간 중의 성장은 경피적 카테터 치료에 대한 수요 증가, 노인 심장 치료에 대한 관심 증가, 하이브리드 심장 수술의 확대, 차세대 판막 기술에 대한 투자 증가, 환자 맞춤형 판막 솔루션의 채택 확대에 기인할 것으로 예측됩니다. 예측 기간의 주요 동향으로는 경피적 카테터 판막 치환술의 채택 증가, 생체 판막에 대한 수요 증가, 최소 침습적 판막 치환술에 대한 선호도 증가, 첨단 판막 수리 기술의 확대, 판막의 내구성과 성능에 대한 관심 강화 등을 들 수 있습니다.

심혈관 질환의 유병률 증가는 심장판막 시장의 성장을 촉진할 것으로 예측됩니다. 흡연, 비만, 운동 부족, 기타 심혈관계 질환 증가는 흡연, 비만, 운동 부족, 기타 심혈관계 질환 증가에 기여하고 있습니다. 동맥내 지방성 플라크 축적을 특징으로 하는 관상동맥질환이 주요 원인 중 하나입니다. 이러한 심장 관련 질환의 급증으로 인해 심장 판막 문제를 해결하기 위한 심장 판막에 대한 수요가 증가하고 있습니다. 2023년 9월 기준 세계보건기구(WHO) 자료에 따르면 심혈관 질환은 비감염성 질환(NCD) 또는 만성질환과 관련된 전 세계 사망원인의 약 74%라는 큰 비중을 차지하고 있습니다.

심장판막 시장의 주요 기업은 승모판막 역류증 환자의 최소침습적 치료에 대한 수요 증가에 대응하기 위해 경대퇴부 카테터 승모판막 치환술(TMVR) 시스템 개발을 추진하고 있습니다. TMVR 시스템은 대퇴정맥을 통해 카테터를 통해 전달되는 접이식 프레임과 생체 판막엽을 사용하여 개흉수술을 피하고 회복기간과 시술 위험을 줄입니다. 2025년 4월, 에드워즈 생명과학는 SAPIEN M3 시스템의 CE 마크 인증을 획득했습니다. 이 시스템은 안정된 판막 팁 포착과 정밀한 생체 판막 전개가 가능한 도킹 메커니즘을 갖추고 위치 조정 및 회수가 가능하여 안전성을 향상시키고, 수술이나 에지 투 에지 수복이 적응증이 아닌 환자들에게 치료 범위를 확대합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

Tariffs are influencing the cardiac valve market by increasing costs of imported biomaterials, precision metal components, manufacturing equipment, and sterilization systems used in mechanical and tissue valves. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported valve products, while Asia-Pacific faces higher production input costs. These tariffs are raising procedure expenses and procurement budgets. However, they are also supporting domestic valve manufacturing, regional innovation, and localized production of advanced cardiac valve solutions.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $12.41 billion in 2025 to $14.24 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising incidence of valvular heart diseases, expansion of cardiac surgery programs, growing use of mechanical heart valves, advancements in surgical valve techniques, increasing availability of cardiac care facilities.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

Major players in the cardiac valve market are advancing transfemoral transcatheter mitral valve replacement (TMVR) systems to address the growing demand for minimally invasive therapies in patients with mitral regurgitation. TMVR systems use collapsible frames and biologic valve leaflets delivered via catheter through the femoral vein, avoiding open-heart surgery and reducing recovery time and procedural risk. In April 2025, Edwards Lifesciences received CE Mark approval for the SAPIEN M3 System, featuring a docking mechanism for stable leaflet capture and precise bioprosthetic valve deployment, enabling repositioning and retrieval to improve safety and expand treatment to patients ineligible for surgery or edge-to-edge repair.

In July 2024, Edwards Lifesciences acquired JenaValve Technology for an upfront USD 500 million, with up to USD 445 million in contingent payments, to expand its cardiac valve portfolio and strengthen its position in aortic regurgitation treatment. The acquisition allows Edwards to integrate JenaValve's Trilogy transcatheter heart valve system, enhancing its offerings in minimally invasive structural heart therapies. JenaValve's expertise in transcatheter valve technologies supports Edwards' strategic growth in high-risk patient populations, reflecting a broader trend in the cardiac device market toward acquisitions that advance portfolio diversification and innovative solutions for complex valve disease.

Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves
• 2) By Position: Aortic Valve; Mitral Valve; Other Positions
• 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
• 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
• Subsegments:
• 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
• 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves; Transcatheter Mitral Valve Replacement (TMVR) Valves
• 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
• Companies Mentioned: Abbott Laboratories; Edwards Lifesciences Corporation; Medtronic plc; Artivion Inc.; Meril Life Sciences Pvt Ltd; Lepu Medical Technology Co Ltd; TTK Healthcare Limited; Braile Biomedica; JenaValve Technology Inc.; Xeltis AG; Colibri Heart Valve LLC; On-X Life Technologies Inc.; Thubrikar Aortic Valve Inc.; LifeNet Health Inc.; Auto Tissue Berlin GmbH; CryoLife Inc.; LivaNova PLC; Foldax Inc.; Micro Interventional Devices Inc.; InnovHeart Srl
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cardiac Valve Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cardiac Valve Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cardiac Valve Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cardiac Valve Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Transcatheter Valve Procedures
  • 4.2.2 Rising Demand For Bioprosthetic Heart Valves
  • 4.2.3 Growing Preference For Minimally Invasive Valve Replacement
  • 4.2.4 Expansion Of Advanced Valve Repair Techniques
  • 4.2.5 Enhanced Focus On Valve Durability And Performance

5. Cardiac Valve Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Specialty Cardiac Centers
• 5.3 Cardiac Research Institutes
• 5.4 Ambulatory Surgical Centers
• 5.5 Teaching Hospitals

6. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiac Valve Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cardiac Valve Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cardiac Valve Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cardiac Valve Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiac Valve Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiac Valve Market Segmentation

• 9.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves
• 9.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Aortic Valve, Mitral Valve, Other Positions
• 9.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiac Valve Repair, Cardiac Valve Replacement
• 9.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
• 9.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
• 9.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves
• 9.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves

10. Cardiac Valve Market Regional And Country Analysis

• 10.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiac Valve Market

• 11.1. Asia-Pacific Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiac Valve Market

• 12.1. China Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiac Valve Market

• 13.1. India Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiac Valve Market

• 14.1. Japan Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiac Valve Market

• 15.1. Australia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiac Valve Market

• 16.1. Indonesia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiac Valve Market

• 17.1. South Korea Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiac Valve Market

• 18.1. Taiwan Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiac Valve Market

• 19.1. South East Asia Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiac Valve Market

• 20.1. Western Europe Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiac Valve Market

• 21.1. UK Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiac Valve Market

• 22.1. Germany Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiac Valve Market

• 23.1. France Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiac Valve Market

• 24.1. Italy Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiac Valve Market

• 25.1. Spain Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiac Valve Market

• 26.1. Eastern Europe Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiac Valve Market

• 27.1. Russia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiac Valve Market

• 28.1. North America Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiac Valve Market

• 29.1. USA Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiac Valve Market

• 30.1. Canada Cardiac Valve Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiac Valve Market

• 31.1. South America Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiac Valve Market

• 32.1. Brazil Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiac Valve Market

• 33.1. Middle East Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiac Valve Market

• 34.1. Africa Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiac Valve Market Regulatory and Investment Landscape

36. Cardiac Valve Market Competitive Landscape And Company Profiles

• 36.1. Cardiac Valve Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cardiac Valve Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cardiac Valve Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Meril Life Sciences Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Cardiac Valve Market Other Major And Innovative Companies

• Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

38. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiac Valve Market

40. Cardiac Valve Market High Potential Countries, Segments and Strategies

• 40.1 Cardiac Valve Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cardiac Valve Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cardiac Valve Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer